3 ms·
From an ethical standpoint, I think they should've just wound down the company. If there are parts of the business that still have value, sell them. Otherwise,
by btmorex 10y ago
From an ethical standpoint, I think they should've just wound down the company. If there are parts of the business that still have value, sell them. Otherwise, give employees decent severance and try to help them find new jobs. Return any remaining money to investors.
- firebones 10y agoNah, it would have been this: "Our foray into nanotainer tech was too early for the market. However, we've established that there is a market for disruptive tech in the stodgy lab biz. In terms of leadership, we're moving on from Ms. Holmes who saw this from the start, and she's agreed that the best for the stakeholders is to step aside due to the misunderstanding around her tech, but the company itself will persevere in breaking the stranglehold Big Lab has on healthcare costs, while Ms Holmes moves to an role in charge of disruptive R&D use of nanotainer and other disruptive tech in the lab/testing biz."
- wiz21c 10y agoDamn that's full buzzword compliant. You should work for Monsanto (a sustainable agriculture company) :-)
- Thrillington 10y agoYou mean Bayer, a "we pretty much just make asprin, don't worry about it" company.
- firebones 10y agoThis reminds me once again to re-watch "Thank You For Smoking".